KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Net Income towards Common Stockholders: 2016-2024

Historic Net Income towards Common Stockholders for Elanco Animal Health (ELAN) over the last 9 years, with Dec 2024 value amounting to $338.0 million.

  • Elanco Animal Health's Net Income towards Common Stockholders fell 109.34% to -$34.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.0 million, marking a year-over-year decrease of 82.44%. This contributed to the annual value of $338.0 million for FY2024, which is 127.46% up from last year.
  • According to the latest figures from FY2024, Elanco Animal Health's Net Income towards Common Stockholders is $338.0 million, which was up 127.46% from -$1.2 billion recorded in FY2023.
  • Elanco Animal Health's Net Income towards Common Stockholders' 5-year high stood at $338.0 million during FY2024, with a 5-year trough of -$1.2 billion in FY2023.
  • For the 3-year period, Elanco Animal Health's Net Income towards Common Stockholders averaged around -$323.7 million, with its median value being -$78.0 million (2022).
  • Per our database at Business Quant, Elanco Animal Health's Net Income towards Common Stockholders plummeted by 1,478.21% in 2023 and then surged by 127.46% in 2024.
  • Elanco Animal Health's Net Income towards Common Stockholders (MRY) stood at -$574.0 million in 2020, then grew by 15.85% to -$483.0 million in 2021, then surged by 83.85% to -$78.0 million in 2022, then tumbled by 1,478.21% to -$1.2 billion in 2023, then skyrocketed by 127.46% to $338.0 million in 2024.
  • Its Net Income towards Common Stockholders stands at $338.0 million for FY2024, versus -$1.2 billion for FY2023 and -$78.0 million for FY2022.